106 related articles for article (PubMed ID: 36331723)
1. PRMT5 promotes retinoblastoma development.
Jiang Y; Zheng G; Sun X
Hum Cell; 2023 Jan; 36(1):329-341. PubMed ID: 36331723
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression.
Tan Z; Chen K; Wu W; Zhou Y; Zhu J; Wu G; Cao L; Zhang X; Guan H; Yang Y; Zhang W; Li J
Theranostics; 2018; 8(18):5143-5158. PubMed ID: 30429891
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
4. MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8.
Liu B; Lu B; Wang X; Jiang H; Kuang W
Childs Nerv Syst; 2019 Aug; 35(8):1303-1311. PubMed ID: 31161266
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
[TBL] [Abstract][Full Text] [Related]
6. EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma.
Liu X; He J; Mao L; Zhang Y; Cui W; Duan S; Jiang A; Gao Y; Sang Y; Huang G
Exp Eye Res; 2021 Jan; 202():108286. PubMed ID: 33035554
[TBL] [Abstract][Full Text] [Related]
7. SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway.
Wu T; Wang LN; Tang DR; Sun FY
Gene Ther; 2017 Jul; 24(7):399-407. PubMed ID: 28485721
[TBL] [Abstract][Full Text] [Related]
8. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2.
Zhu X; Yu M; Wang K; Zou W; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):294-301. PubMed ID: 32152631
[TBL] [Abstract][Full Text] [Related]
10. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
11. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
Webb AH; Gao BT; Goldsmith ZK; Irvine AS; Saleh N; Lee RP; Lendermon JB; Bheemreddy R; Zhang Q; Brennan RC; Johnson D; Steinle JJ; Wilson MW; Morales-Tirado VM
BMC Cancer; 2017 Jun; 17(1):434. PubMed ID: 28633655
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
Wang L; Pal S; Sif S
Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959
[TBL] [Abstract][Full Text] [Related]
13. Clinicohistopathological implications of MMP/VEGF expression in retinoblastoma: a combined meta-analysis and bioinformatics analysis.
Zhu J; Zhang X; Ai L; Yuan R; Ye J
J Transl Med; 2019 Jul; 17(1):226. PubMed ID: 31311559
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
15. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
Jiang Y; Yuan Y; Chen M; Li S; Bai J; Zhang Y; Sun Y; Wang G; Xu H; Wang Z; Zheng Y; Nie H
Theranostics; 2021; 11(18):9162-9176. PubMed ID: 34522232
[No Abstract] [Full Text] [Related]
16. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.
Fu C; Wang S; Jin L; Zhang M; Li M
Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919
[No Abstract] [Full Text] [Related]
17. Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells.
Surgucheva IG; Sivak JM; Fini ME; Palazzo RE; Surguchov AP
Arch Biochem Biophys; 2003 Feb; 410(1):167-76. PubMed ID: 12559990
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
Sun QX; Wang RR; Liu N; Liu C
Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 promotes colorectal cancer growth by interaction with MCM7.
Li X; Wang X; Zhao J; Wang J; Wu J
J Cell Mol Med; 2021 Apr; 25(7):3537-3547. PubMed ID: 33675123
[TBL] [Abstract][Full Text] [Related]
20. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]